GreenCell Mobility, an Indian electric bus platform and Eversource Capital portfolio company, has secured an equity investment of ₹3,300 million (approximately US$35 million) from Impact Fund Denmark. The capital will support the deployment of roughly 4,500 electric buses currently in the company's order book. This infusion positions the Mumbai-based startup to expand its fleet beyond 5,000 electric buses across 105 Indian cities.
Company Background and Business Model
GreenCell Mobility was founded in 2019 and specializes in deploying and operating electric buses for public transportation. It acquires buses through contract manufacturing arrangements with vendors and deploys them for both intercity and intracity travel. The company operates primarily under the NueGo brand and has established a presence across multiple states in India.
Funding Details and Investor Structure
Impact Fund Denmark made the commitment through the Danish SDG Investment Fund II, which pools capital from five Danish pension funds: PKA, PFA, PBU, Pensam, and P+. The investment is covered by a guarantee issued by the European Union under the European Fund for Sustainable Development Plus framework. It marks the fund's third e-mobility investment and reflects an increased focus on clean transportation.
Operational Scale and Growth Plans
GreenCell Mobility currently operates more than 1,200 electric buses in India, including 900 on intra-city routes, 300 under its NueGo inter-city brand, and 50 for MSRTC. The company also runs over 270 charging stations to support its fleet. With the new capital, it plans to execute an order book of nearly 4,500 buses and eventually manage a fleet exceeding 5,000 vehicles across 105 cities.
Environmental and Climate Rationale
The investment targets one of India's most pressing challenges, as 66 of the world's 100 most polluted cities are located in the country. Air pollution is estimated to reduce life expectancy in Delhi by more than eight years. Replacing conventional diesel buses with electric models can reduce greenhouse gas emissions, improve public health, and strengthen energy security by cutting reliance on imported diesel.
Investor Momentum in Electric Mobility
The announcement follows broader investor activity in India's electric bus segment. In March, PMI Electro Mobility and its electric bus platform Allfleet signed an agreement with KKR for up to US$310 million to scale operations. GreenCell has previously raised US$37 million from the World Bank's International Finance Corporation and counts Eversource Capital, British International Investment, and Tata Capital among its backers.
Leadership Commentary
GreenCell Mobility Managing Director and CEO Devndra Chawla said the investment provides greater headroom to accelerate plans while maintaining reliability, efficiency, and customer experience. Eversource Capital CEO Dhanpal Jhaveri noted that electric public mobility is becoming an investable infrastructure asset class in India. Impact Fund Denmark CEO Lars Bo Bertram said India is a central market and scaling electric transportation can contribute to cleaner cities and India's green transition.
Strategic Significance
The funding highlights a shift in investor focus from pure asset financing to the operating platform layer of electric bus services. Large-scale electric bus deployments require capital not only for vehicles but also for charging infrastructure and operational capabilities. GreenCell's ability to secure equity from Danish pension-backed investors signals confidence in its OEM-agnostic business model and long-term public transport contracts.
GreenCell's latest equity round underscores the growing role of long-term institutional capital in India's electric public transportation infrastructure. By combining vehicle deployment with operational capabilities and charging networks, the company is positioned to help accelerate the country's transition to cleaner mobility. The investment illustrates how development finance and private pension capital are converging to support measurable environmental and public health outcomes.